Ocular Therapeutix Inc (OCUL)

EBITDA Margin

-550.06%

Quarterly · Period ending:

OCUL logo

OCUL EBITDA Margin

Latest reported-550.06%
OCUL Quarterly EBITDA Margin (0.00% → -550.06%)
High-resolution chart · PNG

OCUL ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Ocular Therapeutix Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-550.0557%
-783.9777%
-457.1698%
-449.3056%
-473.8242%
-561.6751%
-259.5188%
-209.4652%
-241.0133%
-405.2863%
-162.9012%
25.1973%
-118.787%
-209.8624%
-93.8117%
-182.8834%
-134.6649%
-78.1224%
-12.9997%
40.3933%
-53.0381%
74.176%
-1,132.3854%
-162.7638%
-2,177.6291%
-733.8061%
-1,043.3511%
-1,985.2835%
-3,448.4615%
-3,115.8537%
-3,262.5%
-2,813.8554%
-1,972.6852%
-3,739.4118%
-2,481.3142%
-2,790.4398%
-4,080.3653%
-3,225.0526%
-2,377.8865%
-1,877.1488%
-2,471.6553%
-2,249.7817%
-2,310.7798%
-2,559.4406%
-2,058.3878%
-1,629.108%
-1,461.9802%
-4,738.4615%
-6,129.8969%
-25,451.8519%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.